S. Orange, NJ, United States of America

Jonathan Mark Hexham



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 83(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Jonathan Mark Hexham

Introduction

Jonathan Mark Hexham is a notable inventor based in South Orange, NJ (US). He has made significant contributions to the field of immunology, particularly through his innovative work on immunotoxin fusion proteins. With a total of 3 patents, Hexham's inventions have the potential to impact medical treatments significantly.

Latest Patents

One of his latest patents is focused on immunotoxin fusion proteins and means for expression thereof. This invention provides novel recombinant DT-based immunotoxins, specifically targeting anti-T cell immunotoxin fusion proteins. The patent outlines methods for expressing these immunotoxins in various cell types, including bacterial, yeast, or mammalian cells. The abstract emphasizes that it is designed to help readers quickly ascertain the subject matter of the technical disclosure, ensuring clarity in understanding the scope of the claims.

Career Highlights

Throughout his career, Jonathan Hexham has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Novartis AG. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of immunology.

Collaborations

Some of his notable coworkers include David M Neville and Jerry Todd Thompson. Their collaboration has likely contributed to the advancement of his research and inventions.

Conclusion

Jonathan Mark Hexham's work in immunotoxin fusion proteins showcases his innovative spirit and dedication to advancing medical science. His contributions are poised to make a lasting impact in the field of immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…